Sacituzumab govitecan shows improved survival and quality of life in advanced triple-negative breast cancer, outperforming ...

Sacituzumab govitecan showed lower rates of dose reductions and treatment discontinuations due to adverse effects compared to chemotherapy in TNBC patients. Common adverse effects, such as diarrhea ...

The remaining five Signature Events do not have a cut and allocate 18 percent to the winner. Players qualify for Signature Events via the highest category for which they are eligible on the Priority ...

Discover how tail risk impacts portfolios, why rare financial events matter, and strategies for safeguarding investments against significant, unexpected losses.

Julia is the associate news editor for Health, where she edits and publishes news articles on trending health and wellness topics. Her work has been featured in The Heights, an independent student ...

Discover how S-Scores measure investor sentiment via social media analysis, helping with market decisions and stock performance predictions.

Help us make Medscape the best clinical resource possible. Please use this form to submit your questions or comments on how to make this resource center more useful to clinicians.